Retraction: MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-β2 (PLoS ONE (2015) 10:3 (e0119225) DOI: 10.1371/journal.pone.0119225);MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-β2

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Niu, Guangfeng ^a   Li, Bin ^a   Sun, Li ^a   An, Chenggong ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Dingtao County Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; MESSENGER RNA; MICRORNA; MIRN153 MICRORNA, HUMAN; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR DYNAMICS; OSTEOSARCOMA CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR SUPPRESSOR GENE; BINDING SITE; BONE TUMOR; CHEMISTRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OSTEOSARCOMA; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

BINDING SITES; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MICRORNAS; OSTEOSARCOMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; RNA, MESSENGER; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84925729324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0269902     Document Type: Erratum

References (39)

1. Zhao G, Cai C, Yang T, Qiu X, Liao B, et al. (2013) MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. PLoS One 8: e53906. doi: 10.1371/ journal.pone.0053906 PMID: 23372675
2. Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, et al. (2012) Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 7: e48086. doi: 10.1371/journal.pone. 0048086 PMID: 23133552
3. Liang W, Gao B, Fu P, Xu S, Qian Y, et al. (2013) The miRNAs in the pathgenesis of osteosarcoma. Front Biosci (Landmark Ed) 18: 788-794. PMID: 23276964
4. Yang J, ZhangW(2013) New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 25: 398-406. doi: 10.1097/CCO.0b013e3283622c1b PMID: 23666471
5. Huang J, Gao K, Lin J, Wang Q (2014) MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61. Tumour Biol 35: 1095-1100. doi: 10.1007/s13277-013-1146-8 PMID: 24317814
6. Xu H, Liu X, Zhao J (2014) Down-regulation of miR-3928 promoted osteosarcoma growth. Cell Physiol Biochem 33: 1547-1556. doi: 10.1159/000358718 PMID: 24854843
7. Miao J, Wu S, Peng Z, Tania M, Zhang C (2013) MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumour Biol.
8. Guo S, Bai R, Liu W, Zhao A, Zhao Z, et al. (2014) miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy. Tumour Biol 35: 7025-7034. doi: 10.1007/s13277-014-1965-2 PMID: 24752578
9. Li M, Yu M, Liu C, Zhu H, He X, et al. (2013) miR-34c works downstream of p53 leading to dairy goat male germline stem-cell (mGSCs) apoptosis. Cell Prolif 46: 223-231. doi: 10.1111/cpr.12013 PMID: 23510477
10. Li J, You T, Jing J (2014) MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway. Cell Prolif 47: 152-160. doi: 10.1111/cpr.12093 PMID: 24517182
11. Schirmer U, Doberstein K, Rupp AK, Bretz NP, Wuttig D, et al. (2014) Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma. Oncotarget 5: 462-472. PMID: 24497324
12. Hui W, Yuntao L, Lun L, WenSheng L, ChaoFeng L, et al. (2013) MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PLoS One 8: e54932. doi: 10. 1371/journal.pone.0054932 PMID: 23383003
13. Bier A, Giladi N, Kronfeld N, Lee HK, Cazacu S, et al. (2013) MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Oncotarget 4: 665-676. PMID: 23714687
14. Zhang C, Liu J, Wang X, Wu R, Lin M, et al. (2014) MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling. Oncotarget 5: 9106-9117. PMID: 25193859
15. Li H, Yang BB (2012) Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget 3: 1653-1668. PMID: 23391506
16. Ohdaira H, Sekiguchi M, Miyata K, Yoshida K (2012) MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell Prolif 45: 32-38. doi: 10.1111/j.1365-2184.2011. 00798.x PMID: 22151897
17. Huang J, Zhang SY, Gao YM, Liu YF, Liu YB, et al. (2014) MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell Prolif 47: 277-286. doi: 10.1111/cpr.12109 PMID: 24909356
18. Bronnum H, Andersen DC, Schneider M, Sandberg MB, Eskildsen T, et al. (2013) miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving Programmed Cell Death 4 and Sprouty-1. PLoS One 8: e56280. doi: 10.1371/journal.pone.0056280 PMID: 23441172
19. Nakashima T, Jinnin M, Etoh T, Fukushima S, Masuguchi S, et al. (2010) Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy. PLoS One 5: e14334. doi: 10.1371/journal.pone.0014334 PMID: 21179471
20. Anaya-Ruiz M, Cebada J, Delgado-Lopez G, Sanchez-Vazquez ML, Perez-Santos JL (2013) miR-153 silencing induces apoptosis in the MDA-MB-231 breast cancer cell line. Asian Pac J Cancer Prev 14: 2983-2986. PMID: 23803066
21. Shan N, Shen L, Wang J, He D, Duan C (2014) MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19. Biochem Biophys Res Commun.
22. Yuan Y, Du W, Wang Y, Xu C, Wang J, et al. (2014) Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer. Int J Cancer.
23. Wu Z, He B, He J, Mao X (2013) Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. Prostate 73: 596-604. doi: 10.1002/ pros.22600 PMID: 23060044
24. Xu Q, Sun Q, Zhang J, Yu J, Chen W, et al. (2013) Downregulation of miR-153 contributes to epithelialmesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis 34: 539-549. doi: 10.1093/carcin/bgs374 PMID: 23188671
25. Zhao S, Deng Y, Liu Y, Chen X, Yang G, et al. (2013) MicroRNA-153 is tumor suppressive in glioblastoma stem cells. Mol Biol Rep 40: 2789-2798. doi: 10.1007/s11033-012-2278-4 PMID: 23397238
26. Yu X, Li Z, Shen J, Wu WK, Liang J, et al. (2013) MicroRNA-10b Promotes Nucleus Pulposus Cell Proliferation through RhoC-Akt Pathway by Targeting HOXD10 in Intervetebral Disc Degeneration. PLoS One 8: e83080. doi: 10.1371/journal.pone.0083080 PMID: 24376640
27. Li Z, Lei H, Luo M, Wang Y, Dong L, et al. (2015) DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer 18: 43-54. doi: 10.1007/s10120-014-0340-8 PMID: 24481854
28. Zhang L, Pickard K, Jenei V, Bullock MD, Bruce A, et al. (2013) miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance. Cancer Res 73: 6435-6447. doi: 10.1158/0008-5472.CAN-12-3308 PMID: 23950211
29. Perera M, Tsang CS, Distel RJ, Lacy JN, Ohno-Machado L, et al. (2010) TGF-beta1 interactome: metastasis and beyond. Cancer Genomics Proteomics 7: 217-229. PMID: 20656987
30. Schedlich LJ, Yenson VM, Baxter RC (2013) TGF-beta-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells. Mol Cell Endocrinol 377: 56-64. doi: 10.1016/j.mce. 2013.06.033 PMID: 23831640
31. Lyu X, Fang W, Cai L, Zheng H, Ye Y, et al. (2014) TGFbetaR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness. Mol Cancer 13: 51. doi: 10.1186/1476-4598-13-51 PMID: 24606633
32. Kato M, Putta S, Wang M, Yuan H, Lanting L, et al. (2009) TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11: 881-889. doi: 10.1038/ ncb1897 PMID: 19543271
33. Taylor MA, Sossey-Alaoui K, Thompson CL, Danielpour D, SchiemannWP (2013) TGF-beta upregulates miR-181a expression to promote breast cancer metastasis. J Clin Invest 123: 150-163. doi: 10. 1172/JCI64946 PMID: 23241956
34. Chaussepied M, Janski N, Baumgartner M, Lizundia R, Jensen K, et al. (2010) TGF-b2 induction regulates invasiveness of Theileria-transformed leukocytes and disease susceptibility. PLoS Pathog 6: e1001197. doi: 10.1371/journal.ppat.1001197 PMID: 21124992
35. Matsuyama S, Iwadate M, Kondo M, Saitoh M, Hanyu A, et al. (2003) SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells. Cancer Res 63: 7791-7798. PMID: 14633705
36. Pang L, Li Q,Wei C, Zou H, Li S, et al. (2014) TGF-beta1/Smad Signaling Pathway Regulates Epithelial-to-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma: In Vitro and Clinical Analyses of Cell Lines and Nomadic Kazakh Patients from Northwest Xinjiang, China. PLoS One 9: e112300. doi: 10.1371/journal.pone.0112300 PMID: 25464508
37. Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, et al. (2002) Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 156: 299-313. PMID: 11790801
38. Hou CH, Lin FL, Tong KB, Hou SM, Liu JF (2014) Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K/Akt signaling pathway. Biochem Pharmacol 89: 453-463. doi: 10.1016/j.bcp.2014.03.010 PMID: 24685520
39. Sung JY, Park SY, Kim JH, Kang HG, Yoon JH, et al. (2014) Interferon consensus sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal transition (EMT)-like phenomena, cell-motility, and invasion via TGF-beta signaling in U2OS cells. Cell Death Dis 5: e1224. doi: 10.1038/cddis.2014. 189 PMID: 24832596